CompuMed Signs Contract With Veritas Collaborative to Screen for Cardiac Conditions in Patients With Eating Disorders
14 September 2012 - 6:41AM
Marketwired
CompuMed, Inc. (PINKSHEETS: CMPD) (
www.compumed.net ) -- a leader in telemedicine services
for patient diagnosis and management -- has signed a contract with
Veritas Collaborative (
www.veritascollaborative.com), a specialty behavioral
health hospital for young people with eating disorders. CompuMed
will provide CardioGramâ„¢ electrocardiogram (ECG) remote over-read
services to patients who may have pre-existing cardiac disorders or
those who may develop cardiac problems due to anorexia and other
related conditions.
Maurizio Vecchione, CompuMed's CEO, made the announcement
saying, "We understand the difficulty in treating eating disorders
as Veritas patients may also have other underlying conditions such
as cardiac problems. It is not uncommon to find bradycardia
indicating electrical problems in the heart, as well as ECG
findings of low voltage or prolonged QT interval, all relating to a
possible eating disorder." He added that in anorexia, cardiac
insufficiency is a major concern because as the heart loses
contractility and mass, patients can be at risk of heart
failure.
Veritas Collaborative Medical Director Dr. Ana Carla Smith will
rely on CompuMed to provide ECG testing to those patients with
cardiac risk factors and for general screening. "CompuMed is
helping us to provide our patients with the highest level of
cardiac care using the most accurate cardiac assessment."
The CardioGram system reduces healthcare costs significantly by
providing remote cardiac screening at the point-of-care and
reducing unnecessary transports to emergency rooms. However, the
most unique and life-saving feature of the CardioGram is the
device's over-read capabilities or "The Doctor Insideâ„¢," which
immediately engages one of CompuMed's on-call cardiologists to
over-read the computerized interpretation. Cardiologist over-reads
can be made available to attending physicians at the point-of-care
providing expert interpretations in those situations where the data
is ambiguous or difficult to interpret. "The Doctor Inside" is a
key element of CompuMed's unique approach to telemedicine and
telecardiology.
For more information, contact CompuMed at 310- 258-5000 or sales
at (310) 258-5033.
About CompuMed CompuMed's diagnostic and
management tools for the healthcare community focus on
telecardiology systems and software solutions. We offer analysis
and remote monitoring for patients with cardiovascular and
musculoskeletal diseases designed to improve healthcare provider
workflow and patient care while reducing costs. CompuMed is
headquartered in Los Angeles and distributes its products worldwide
both directly and through OEM partners. Visit CompuMed at
www.compumed.net and follow on Twitter @compumed.
About Veritas Collaborative Located in
Durham, NC and accredited by The Joint Commission, Veritas
Collaborative provides comprehensive, evidence-based care for young
males and females with eating disorders & their families -- all
within a space intentionally-designed as a locus of engagement
& place in which young people can thrive. To learn more about
Veritas Collaborative, including the services that they provide and
to schedule a visit to Veritas Collaborative's state-of-the-art
center, please visit www.veritascollaborative.com or call (919)
908-9730.
Forward Looking Statement Statements
contained in this press release that are not historical facts, such
as statements about prospective earnings, savings, revenue,
operations, revenue and earnings growth, results of contracts and
other financial results, are forward-looking statements pursuant to
the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995. All such forward-looking statements including
statements concerning the Company's plans, objectives, expectations
and intentions are based largely on management's expectations and
are subject to and qualified by risks and uncertainties that could
cause actual results to differ materially from those expressed or
implied by such statements. These statements are subject to
uncertainties and risks including, without limitation, competitive
factors, outsourcing trends in the pharmaceutical industry, product
and service demand and acceptance, changes in technology, ability
to raise capital, the availability of appropriate acquisition
candidates and/or business partnerships, economic conditions, the
impact of competition and pricing, capacity and supply constraints
or difficulties, government regulation and other risks identified
in the Company's filings with the Securities and Exchange
Commission and OTC Pink operated by OTCMarkets. All such
forward-looking statements are expressly qualified by these
cautionary statements. The Company expressly disclaims any
obligation or undertaking to release publicly any updates or
revisions to any forward-looking statements to reflect events,
conditions or circumstances on which any such statement is based
after the date hereof, except as required by law.
Press Contact: Susan Tellem Tellem Grody Public Relations
+1 310-313-3444 susan@tellemgrodypr.com
Common Stock (PK) (USOTC:CMPD)
Historical Stock Chart
From Dec 2024 to Jan 2025
Common Stock (PK) (USOTC:CMPD)
Historical Stock Chart
From Jan 2024 to Jan 2025